CMI editorial report 2013 Clinical Microbiology and Infection

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain  A. Doménech-Sánchez  Clinical Microbiology.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
Public health microbiology, a challenge for Europe
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
P. Balraj, G. Vestris, D. Raoult, P. Renesto 
Nocardiosis in Quebec, Canada, 1988–2008
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
An eye-catching acanthocephalan
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Prevalence of Toscana virus antibodies in residents of Croatia
Clinical Microbiology and Infection
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008  C.-K. Tan, C.-C.
Elements of design: the knowledge on which we build
Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product  T.G. Bromage  Clinical Microbiology.
Levofloxacin in the treatment of ventilator-associated pneumonia
Metagenomics and probiotics
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Update on antifungal resistance in Aspergillus and Candida
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Current experience in treating invasive zygomycosis with posaconazole
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Antimicrobial drug development – the past, the present, and the future
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Listeriosis: a resurgent foodborne infection
Real-time comparative monitoring of the A/H1N1 pandemic in France
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Influence of climate change on the incidence and impact of arenavirus diseases: a speculative assessment  J.C. Clegg  Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
The state of measles and rubella in the WHO European Region, 2013
S. Shpynov, N. Rudakov, Y. Tohkov, A. Matushchenko, I. Tarasevich, D
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
CMI editorial report, 2016 Clinical Microbiology and Infection
Great oaks from little acorns grow—21 years of CMI
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

CMI editorial report 2013 Clinical Microbiology and Infection C. Yelnik, R. Cousens, D. Raoult  Clinical Microbiology and Infection  Volume 19, Issue 1, Pages 1-7 (January 2013) DOI: 10.1111/1469-0691.12065 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Wealth and scientific production currently go together. The map (a) extracted from Wikipedia (February 2012), shows the gross domestic product (GDP) per capita, the usual way to measure the wealth of states. The map (b) presents what can be called the current state of ‘science domestic production’ per capita. Using the same principle as the GDP, this was calculated by gathering, for each country, the number of scientific publications, including all fields, over the previous 5 years (2007–2011) and calculating a ratio with the number of inhabitants. This results in the number of publications per capita. Clinical Microbiology and Infection 2013 19, 1-7DOI: (10.1111/1469-0691.12065) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Growing rates of gross domestic product (GDP) and scientific production also go together. (a) Made by calculating the real GDP growth rate over the previous year (2011). (b) Made by calculating the growth rate of scientific production in ‘all fields’ between 2001 and 2011. Clinical Microbiology and Infection 2013 19, 1-7DOI: (10.1111/1469-0691.12065) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 The rate of evolution scientific production in microbiology. (a) The number of publications per capita in microbiology over the last 5 years (2007–2011). (b) The growing rate of publications in microbiology between 2001 and 2011. Clinical Microbiology and Infection 2013 19, 1-7DOI: (10.1111/1469-0691.12065) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 4 The geographical distribution of CMI submissions and publications between 2010 and June 2012. (a) The national submission ratios per capita. (b) The national acceptance rates. Clinical Microbiology and Infection 2013 19, 1-7DOI: (10.1111/1469-0691.12065) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions